Tausif Shaikh
Stock Analyst at Exane BNP Paribas
(n/a)
# 5,084
Out of 5,104 analysts
3
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tausif Shaikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RDY Dr. Reddy's Laboratories | Upgraded: Buy | $15 | $14.30 | +3.50% | 1 | Oct 12, 2026 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Reiterated: Hold | ₹1,311 | ₹1,702 | n/a | 1 | May 28, 2025 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Reiterated: Hold | ₹996.00 | ₹1,259 | n/a | 1 | May 20, 2025 |
Dr. Reddy's Laboratories
Oct 12, 2026
Upgraded: Buy
Price Target: $15
Current: $14.30
Upside: +3.50%
Aurobindo Pharma Limited
May 28, 2025
Reiterated: Hold
Price Target: ₹1,311
Current: ₹1,702
Upside: n/a
Zydus Lifesciences Limited
May 20, 2025
Reiterated: Hold
Price Target: ₹996.00
Current: ₹1,259
Upside: n/a